Last updated: August 3, 2021
Sponsor: Istanbul University
Overall Status: Completed
Phase
2/3
Condition
Acute Respiratory Distress Syndrome (Ards)
Lung Injury
Treatment
N/AClinical Study ID
NCT04990830
E-66175679-514.03.01-328141
46325
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Positive reserve transcriptase polymerase chain reaction (RT-PCR) test ofnasopharyngeal swab for COVID- 19, and pneumonia confirmed by a Computed Tomography (CT).
- Negative reserve transcriptase polymerase chain reaction (RT-PCR) test ofnasopharyngeal swab for COVID- 19, but radiological and biochemical examinationsunambiguously suggest COVID-19, when other possible diagnoses were excluded.
Exclusion
Exclusion Criteria:
- Pregnancy
- History of heparin and associated drug allergies.
Study Design
Total Participants: 80
Study Start date:
February 03, 2021
Estimated Completion Date:
May 21, 2021
Study Description
Connect with a study center
Istanbul University Medical Faculty
Istanbul, Fatih 34093
TurkeySite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.